Overview

Neurovascular thrombectomy devices market is poised to value USD 951 million by 2028 end at a CAGR of 6.4% during the forecast period 2022 to 2028.

Neurovascular disorders and an aging population are contributing to the increase in demand for Neurovascular Thrombectomy Devices. Additionally, technologically advanced products and campaigns aimed at increasing awareness of neurovascular illnesses and their prevention are expected to drive the market for Neurovascular Thrombectomy Devices. With the increase in neurovascular disorders and an aging population, the demand for neurovascular thromboembolism devices is on the rise. The development of technologically sophisticated products and initiatives to raise awareness about neurovascular illnesses and their prevention are some other factors anticipated to fuel the market for Neurovascular Thrombectomy Devices. As part of efforts to raise awareness about ischemic strokes and prevention methods, a variety of government and non-profit organizations are working together. A supportive reimbursement policy and government subsidies also play an important role in driving the market growth. Device acceptance and awareness will contribute to the growth of the neurovascular thrombectomy market. There are various types of neurovascular devices on the market, including embolic protection devices, embolic coils, intracranial stents, intravascular devices, etc. The embolic coils segment will experience growth due to the rising occurrence of brain aneurysms and ischemic strokes. Embolization coils and occlusion devices may be used for individuals at substantial or prohibitive surgical risk to successfully eradicate a residual central aorta to the pulmonary artery. As the need for less invasive procedures like coil embolization increases, the demand for embolic coils will increase as well.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Neurovascular Thrombectomy Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share, and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.

According to the research study conducted by FutureWise research analysts, the market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the Neurovascular Thrombectomy Devices Market along with the growth opportunities present across this business vertical.

Key Market Players: 

• Medtronic Plc
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Johnson & Johnson Services, Inc.
• Penumbra Inc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Acandis GmbH
• Argon Medical Inc

Neurovascular Thrombectomy Market: Segmentation
By Product Type

• Stent Retriever
• Aspiration Catheter 

By End User

• Hospitals
• Neuro-Catheterization Labs
• Specialized Neurosurgery Centers

By Region:

• Europe
• North America 
• Asia-Pacific
• Latin America
• Middle East and Africa

Neurovascular Thrombectomy Devices Market Sample Video:

Competitive Landscape: 

• Tier 1 players- established companies in the market with a major market share 
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants  

FutureWise Takeaways 

• Growth prospects 
• SWOT analysis
• Key trends
• Key data points affecting market growth 

Objectives of the Study:

• To provide an exhaustive analysis on the neurovascular thrombectomy market by product, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies 

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
    2.1. Research Data 
         2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
                2.1.2.1. Key Data from Primary Sources
    2.2. Market Size Estimation 
    2.3. Market Breakdown and Data Triangulation 
    2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Neurovascular Thrombectomy Devices Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Type Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Neurovascular Thrombectomy Devices Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Neurovascular Thrombectomy Devices Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Type Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Type Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Neurovascular Thrombectomy Devices Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Stent Retriever
   7.2. Aspiration Catheter

8. Neurovascular Thrombectomy Devices Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Hospitals
   8.2. Neuro-Catheterization Labs
   8.3. Specialized Neurosurgery Centers

9. North America Neurovascular Thrombectomy Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   9.1. Introduction
   9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
        9.2.1. U.S.A
        9.2.2. Canada
        9.2.3. Mexico
   9.3. Market Size (USD Million) Forecast for North America 2022-2028

10. Latin America Neurovascular Thrombectomy Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. Brazil
          10.2.2. Venezuela
          10.2.3. Argentina
          10.2.4. Rest of Latin America
    10.3. Market Size (USD Million) Forecast for Latin America 2022-2028

11. Europe Neurovascular Thrombectomy Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Germany
          11.2.2. U.K         
          11.2.3. France
          11.2.4. Italy
          11.2.5. Spain
          11.2.6. Russia
          11.2.7. Poland
          11.2.8. Rest of Europe
    11.3. Market Size (USD Million) Forecast for Europe 2022-2028

12. Asia Pacific Neurovascular Thrombectomy Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Japan
          12.2.2. China
          12.2.3. India
          12.2.4. Australia and New Zealand
          12.2.5. ASEAN
          12.2.6. Rest of Asia Pacific
    12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. GCC
          13.2.2. Israel
          13.2.3. South Africa
          13.2.4. Rest of MEA
    13.3. Market Size (USD Million) Forecast for MEA 2022-2028

14. Market Share Analysis and Competitive Landscape   
    14.1. Global Landscape - Key Players, Revenue and Presence
    14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    14.3. Global Emerging Companies
    14.4. North America - Market Share Analysis and Key Regional Players
    14.5. Europe - Market Share Analysis and Key Regional Players
    14.6. Asia Pacific - Market Share Analysis and Key Regional Players
    14.7. Global Key Player - Growth Matrix

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    15.1. Medtronic Plc
          15.1.1. Company Overview
          15.1.2. Product Portfolio
          15.1.3. SWOT Analysis
          15.1.4. Financial Overview
          15.1.5. Strategic Overview
    15.2. Stryker Corporation
          15.2.1. Company Overview
          15.2.2. Product Portfolio
          15.2.3. SWOT Analysis
          15.2.4. Financial Overview
          15.2.5. Strategic Overview                         
    15.3. Teleflex Incorporated
          15.3.1. Company Overview
          15.3.2. Product Portfolio
          15.3.3. SWOT Analysis
          15.3.4. Financial Overview
          15.3.5. Strategic Overview
    15.4. Terumo Corporation
          15.4.1. Company Overview
          15.4.2. Product Portfolio
          15.4.3. SWOT Analysis
          15.4.4. Financial Overview
          15.4.5. Strategic Overview
    15.5. Johnson & Johnson Services, Inc.
          15.5.1. Company Overview
          15.5.2. Product Portfolio
          15.5.3. SWOT Analysis
          15.5.4. Financial Overview
          15.5.5. Strategic Overview          
    15.6. Penumbra Inc.
          15.6.1. Company Overview
          15.6.2. Product Portfolio
          15.6.3. SWOT Analysis
          15.6.4. Financial Overview
          15.6.5. Strategic Overview      
    15.7. Boston Scientific Corporation
          15.7.1. Company Overview
          15.7.2. Product Portfolio
          15.7.3. SWOT Analysis
          15.7.4. Financial Overview
          15.7.5. Strategic Overview
    15.8. Edwards Lifesciences Corporation
          15.8.1. Company Overview
          15.8.2. Product Portfolio
          15.8.3. SWOT Analysis
          15.8.4. Financial Overview
          15.8.5. Strategic Overview 
    15.9. Acandis GmbH
          15.9.1. Company Overview
          15.9.2. Product Portfolio
          15.9.3. SWOT Analysis
          15.9.4. Financial Overview
          15.9.5. Strategic Overview 
    15.10.Argon Medical Inc       
          15.10.1. Company Overview
          15.10.2. Product Portfolio
          15.10.3. SWOT Analysis
          15.10.4. Financial Overview
          15.10.5. Strategic Overview 

16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations

17. FutureWise SME Key Takeaway Points for Client

Tables

Figures